Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 22:15:1326212.
doi: 10.3389/fendo.2024.1326212. eCollection 2024.

Osteoporosis in Parkinson's disease and the role of lean body mass: a cross-sectional study in a Brazilian tertiary center

Danielle Pessoa Lima  1   2   3 , Francisco Abaeté das Chagas-Neto  4   5 , João Rafael Gomes de Luna  1 , Yasmin de Oliveira Martins  1 , Samuel Brito de Almeida  3 , Camila Ximenes Feitosa  2 , Leticia Brasil Gradvohl  2 , Isabele Dantas Rosa  1 , Fábia Karine de Moura Lopes  3 , Luciana Felipe Férrer Aragão  3   6 , Antonio Brazil Viana-Júnior  3 , Kristopherson Lustosa Augusto  2   7 , Jarbas de Sá Roriz-Filho  1 , Catarina Brasil d'Alva  6 , Renan Magalhães Montenegro-Júnior  3   6 , Pedro Braga-Neto  8   9
Affiliations

Osteoporosis in Parkinson's disease and the role of lean body mass: a cross-sectional study in a Brazilian tertiary center

Danielle Pessoa Lima et al. Front Endocrinol (Lausanne). .

Abstract

Background: Parkinson's disease (PD) is the second most common neurodegenerative illness and has the highest increase rate in recent years. There is growing evidence to suggest that PD is linked to higher osteoporosis rates and risk of fractures.

Objective: This study aims to estimate the prevalence and factors associated with osteoporosis as defined by the National Osteoporosis Foundation (NOF) and World Health Organization in patients with mild to moderate PD.

Methods: We performed a cross-sectional study at a tertiary public hospital in Fortaleza, Brazil, dating from May 2021 until April 2022. The study sample was comprised of patients with mild to moderate PD who were at least 40 years old and who had the ability to walk and stand unassisted. Bone Mineral Density (BMD) of both the hip (neck of the femur) and the lumbar spine were obtained via properly calibrated Dual Energy X-ray Absorptiometry (DXA) scanning. The FRAX (Fracture Risk Assessment Tool) score was used to determine a person's 10-year risk of major osteoporotic fracture. The Revised European Working Group on Sarcopenia in Older People (EWGSOP 2) was used as a basis to confirm a sarcopenia diagnosis with the following parameters: low muscle strength gauged by handgrip strength and low muscle quantity by DXA. Physical performance was carefully evaluated by using the Short Physical Performance Battery test. Osteoporosis and osteopenia were diagnosed following the NOF guidelines and WHO recommendations.

Results: We evaluated 107 patients in total, of whom 45 (42%) were women. The group's mean age was 68 ± 9 years, and the mean disease time span was 9.9 ± 6.0 years and mean motor UPDRS was 43 ± 15. We found that 42.1% and 34.6% of the sample had osteopenia and osteoporosis following NOF criteria, respectively, and 43% and 33.6% following the WHO recommendations. Lower lean appendicular mass was associated to osteopenia and osteoporosis in multinomial logistic regression analysis in both diagnostic criteria.

Conclusion: Our findings provide additional evidence for the protective role of lean mass against osteoporosis in patients with PD.

Keywords: Parkinson’s disease; falls; osteopenia; osteoporosis; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Association between appendicular lean mass which was adjusted for height in meters squared, as well as bone mass.
See this image and copyright information in PMC

References

    1. Bloem BR, Okun MS, Klein C. Parkinson’s disease. Lancet. (2021) 397:2284–303. doi: 10.1016/S0140-6736(21)00218-X - DOI - PubMed
    1. Brundin P. Parkinson disease epidemiology, pathology, genetics and pathophysiology. Physiol Behav. (2017) 176:139–48. doi: 10.1016/j.cger.2019.08.002.Parkinson - DOI - PMC - PubMed
    1. Lamont RM, Morris ME, Menz HB, McGinley JL, Brauer SG. Falls in people with Parkinson’s disease: A prospective comparison of community and home-based falls. Gait Posture. (2017) 55:62–7. doi: 10.1016/j.gaitpost.2017.04.005 - DOI - PubMed
    1. Raglione LM, Sorbi S, Nacmias B. Osteoporosis and parkinson’s disease. Clin cases Miner Bone Metab. (2011) 8:16–8. doi: 10.1155/2012/127362 - DOI - PMC - PubMed
    1. Kanis JA. Assessment of osteoporosis at the primary health care level Vol. 339. UK: World Health Organization Collaborating Centre for Metabolic Bone Diseas, UK: (2007). Available at: www.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf.

Publication types